Life Neuroscience
NeuroLife
Thu, Oct 15, 2026
[Archive]
Volume 1, Issue 1 (1-2023)
Neuroscience Updates 2023, 1(1): 15-21 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Haider F, Shaidy N, Haszlihisham H, Shaharudin N, Jalil N, Mohamed W. Nutrition and Parkinson’s Disease: What is the interplay?. Neuroscience Updates 2023; 1 (1) :15-21
URL: http://neuroupdates.de/article-1-96-en.html
URL: http://neuroupdates.de/article-1-96-en.html
Fatimah Haider1 
, Noor Shaidy1 , Husna Haszlihisham1 , Nursyafiqah Shaharudin2 , Nur Jalil2 , Wael Mohamed *3 
, Noor Shaidy1 , Husna Haszlihisham1 , Nursyafiqah Shaharudin2 , Nur Jalil2 , Wael Mohamed *3
1- Department of Chemistry, Kulliyyah of Science, International Islamic University Malaysia (IIUM), Pahang, Malaysia
2- Department of Nutrition Sciences, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia (IIUM), Pahang, Malaysia
3- Department of Basic Medical Science, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM), Pahang, Malaysia
2- Department of Nutrition Sciences, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia (IIUM), Pahang, Malaysia
3- Department of Basic Medical Science, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM), Pahang, Malaysia
Abstract: (5487 Views)
Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease and affects about 1% of the population over the age of 60 years in industrialized countries. This review aims to examine nutrition in PD. The Parkinson's disease patients has increased over the past few years to 8.5 million people in 2019. Early-stage symptoms of Parkinson's disease such as malnutrition and weight loss are eminently related to nutrition. Parkinson's disease (PD) is a progressive neurological disorder characterized by motor and non-motor features. The clinical characteristics of PD are associated to dopamine deficiency in the substantia nigra pars compacta. The causes of Parkinson's disease in terms of biochemical factors such as dopaminergic neuron loss and MPTP neurotoxins that cause neuronal death are addressed. Individuals with PD are at increased risk of malnutrition due to the increased metabolic demands and disease pathophysiology. The risk of malnutrition is further complicated by anosmia, swallowing difficulties, constipation, and drug-nutrient interactions. An emerging body of evidence suggests that the intestinal tract is affected early in the disease, creating therapeutic opportunities for early intervention. Dietary modification and nutritional supplementation may improve symptoms of constipation, depression, insomnia, dystonia, and help prevent cognitive dysfunction. Edible bird's nest which is high in neuroprotective chemicals, shows good potential against Parkinson's disease. It is important to understand the interplay between PD, comorbidities, and nutritional status. The positive impact of vigorous aerobics exercise for Parkinson's disease patients is also emphasized. Physical exercise will enhance PD patients' motor function and brain health. Increasing understanding of the relationship between nutrition and Parkinson's disease will lead to the future discovery of the disease's etiology. Further research may contribute to developing interventional strategies to improve symptoms, augment care, and significantly enhance the quality of life for patients with this complex neurodegenerative disease. This review summarizes the state of the science related to nutrition and non-motor symptoms of PD.
Type of Study: Review Article |
Subject:
Basic Neuroscience
Received: 2023/06/15 | Accepted: 2023/08/30 | Published: 2023/09/15
Received: 2023/06/15 | Accepted: 2023/08/30 | Published: 2023/09/15
References
1. Jackson, A., Forsyth, C. B., Shaikh, M., et al. Diet in Parkinson's Disease: Critical Role for the Microbiome. Frontiers in Neurology. 2019; 10. [DOI:10.3389/fneur.2019.01245] [PMID] [PMCID]
2. Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. Challenges in the diagnosis of Parkinson's disease. The Lancet Neurology. 2021; 20(5), 385-397. [DOI:10.1016/S1474-4422(21)00030-2] [PMID]
3. Bexci, S., & Subramani, R. Decoding Parkinson's Associated Health Messages in Social Media Pages by Malaysian Service Administrators. Malaysian Journal of Medical Research. 2018; 02(04), 64-72. [DOI:10.31674/mjmr.2018.v02i04.009]
4. Church, F. C. Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease. Biomolecules. 2021; 11(4), 612. [DOI:10.3390/biom11040612] [PMID] [PMCID]
5. Du, X., Xie, X., & Liu, R. The Role of α-Synuclein Oligomers in Parkinson's Disease. International Journal of Molecular Sciences. 2020; 21(22), 8645. [DOI:10.3390/ijms21228645] [PMID] [PMCID]
6. Ongun, N. Does nutritional status affect Parkinson's Disease features and quality of life? PLOS ONE. 2018; 13(10), e0205100. [DOI:10.1371/journal.pone.0205100] [PMID] [PMCID]
7. Sonne, J., Reddy, V., & Beato, M. R. Neuroanatomy, Substantia Nigra. PubMed; Stat Pearls Publishing. 2021. https://www.ncbi.nlm.nih.gov/books/NBK536995/
8. Bové, J., Prou, D., Perier, C., & Przedborski, S. The Journal of the American Society for Experimental NeuroTherapeutics. Toxin-Induced Models of Parkinson's Disease. 2005; 2(3): 484-491. [DOI:10.1602/neurorx.2.3.484] [PMID] [PMCID]
9. Sivanandy P., Leey T. C., Xiang T. C., et al. Systematic review on Parkinson's disease medications, emphasizing on three recently approved drugs to control Parkinson's symptoms. International journal of environmental research and public health. 2021; 19(1): 364. [DOI:10.3390/ijerph19010364] [PMID] [PMCID]
10. Johns Hopkins Medicine. Fighting Parkinson's Disease with Exercise and Diet. https://www.hopkinsmedicine.org/health/conditions-and-diseases/parkinsons-disease/fighting parkinson-disease-with-exercise-and-diet
11. Mei Y. Y., Rhun Y. K., Soi M. C., Othman I., Khuen Y. N. Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells. BMC complementary and alternative medicine. 2014; 14(1): 12. [DOI:10.1186/1472-6882-14-391] [PMID] [PMCID]
12. Oliveira de Carvalho, A., Filho, et al. Physical Exercise for Parkinson's Disease: Clinical and Experimental Evidence. Clinical Practice & Epidemiology in Mental Health. 2018; 14(1), 89-98. [DOI:10.2174/1745017901814010089] [PMID] [PMCID]
13. Li, K. P., Zhang, et al. Effect of music-based movement therapy on the freezing of gait in patients with Parkinson's disease: A randomised controlled trial. Frontiers in Aging Neuroscience. 2022; 14, 924784. [DOI:10.3389/fnagi.2022.924784] [PMID] [PMCID]
14. Cammisuli, D. M., Bonuccelli, et al. Aerobic exercise and healthy nutrition as neuroprotective agents for brain health in patients with Parkinson's disease: A critical review of the literature. Antioxidants. 2020; 9(5), 380. [DOI:10.3390/antiox9050380] [PMID] [PMCID]
15. Wang, Z., Guo, et al. Exercise alters resting-state functional connectivity of motor circuits in parkinsonian rats. Neurobiology of aging. 2015; 36(1), 536-544. [DOI:10.1016/j.neurobiolaging.2014.08.016] [PMID] [PMCID]
16. Li, S., Dong, et al. Therapies for Parkinson's diseases: alternatives to current pharmacological interventions. Journal of neural transmission. 2016; 123, 1279-1299. [DOI:10.1007/s00702-016-1603-9] [PMID]
17. Institute for Scientific Information on Coffee. Coffee and neurodegenerative disorders: coffee and Parkinson's disease. [Link]
18. Ma, K., Xiong, N., Shen, Y., et al. Weight loss and malnutrition in patients with Parkinson's disease: current knowledge and future prospects. Frontiers in aging neuroscience. 2018; 10, 1. [DOI:10.3389/fnagi.2018.00001] [PMID] [PMCID]
19. Baert, F., Matthys, C., Mellaerts, R., Lemaître, D., Vlaemynck, G., & Foulon, V. Dietary Intake of Parkinson's Disease Patients. Frontiers in Nutrition. 2020; 7. [DOI:10.3389/fnut.2020.00105] [PMID] [PMCID]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
.png)
